-
Zolgensma (AVXS-101) Provisionally Approved
<p style=”text-align: left;”>Zolgensma is provisionally approved by FDA. The company now needs to request approval for market authorization (BLA approval).</p>
https://www.novartis.com/news/media-releases/novartis-highlights-company-transformation-catalyst-rich-pipeline-and-strong-progress-strategy-meet-novartis-management-investor-event -
2 Replies
-
Just the name Zolgensma has been approved, the treatment itself has not been yet.
-
Thanks for sharing this Krystal. Yeah the full FDA-approval is expected to be soon. We’ll keep everyone updated.
Log in to reply.